Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / IASO Biotechnology
Entity

IASO Biotechnology

Tracked across 1 events · 6 articles · First seen Jul 20, 2026 · Last active Aug 14, 2026

Sentiment
70
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 70
Business
IASO Bio acquires MediSix Therapeutics
IASO Biotechnology, a Chinese commercial-stage biopharmaceutical company, announced the completion of its acquisition of MediSix Therapeutics, a Singapore-based immune cell engineering and cell therapy company. The acquisition integrates MediSix's proprietary PEBL (Protein Expression Blocker) platform,…
Impact: Acquirer; strengthens global R&D and pipeline, likely positive for stock.
Jul 20, 2026 · 6 articles
Key Actions (1)
100 IASO Biotechnology acquired MediSix TherapeuticsIASO Bio acquires MediSix...
ERGEN INTELLIGENCE
Track IASO Biotechnology live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.